TY - JOUR
T1 - Long-Term Follow-Up of Children, Adolescents, and Young Adult Cancer Survivors
AU - Hilgendorf, Inken
AU - Bergelt, Corinna
AU - Bokemeyer, Carsten
AU - Kaatsch, Peter
AU - Seifart, Ulf
AU - Stein, Alexander
AU - Langer, Thorsten
N1 - Publisher Copyright:
© 2021 S. Karger AG, Basel. Copyright: All rights reserved.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/3
Y1 - 2021/3
N2 - Background and Summary: Thanks to increasing cure rates to currently >80%, children, adolescents, and young adults (CAYA) survive their cancer much more frequently today than decades ago. Due to their long life expectancy, CAYA cancer survivors are at a particular risk of long-term sequelae from the cancer itself or the therapy applied; this requires specific follow-up, and preventative or even therapeutic interventions. Thus, compared to the normal population, morbidity and mortality may be significantly increased. In 2 of 3 survivors, the cancer and the respective treatment can lead to late effects, even after 30 years, which require specific therapy; in about one-third of these cases, these effects are classed as severe. Applying structured follow-up could identify these late effects at an early stage and initiate immediate treatment. In 2018, a working group dealing with long-term survival after cancer detected <40 years of age was founded within the framework of the National Cancer Plan of the German Federal Ministry of Health.
AB - Background and Summary: Thanks to increasing cure rates to currently >80%, children, adolescents, and young adults (CAYA) survive their cancer much more frequently today than decades ago. Due to their long life expectancy, CAYA cancer survivors are at a particular risk of long-term sequelae from the cancer itself or the therapy applied; this requires specific follow-up, and preventative or even therapeutic interventions. Thus, compared to the normal population, morbidity and mortality may be significantly increased. In 2 of 3 survivors, the cancer and the respective treatment can lead to late effects, even after 30 years, which require specific therapy; in about one-third of these cases, these effects are classed as severe. Applying structured follow-up could identify these late effects at an early stage and initiate immediate treatment. In 2018, a working group dealing with long-term survival after cancer detected <40 years of age was founded within the framework of the National Cancer Plan of the German Federal Ministry of Health.
UR - http://www.scopus.com/inward/record.url?scp=85100891777&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/903347b1-30e1-3ae8-964d-d23d0fb9c3f1/
U2 - 10.1159/000514381
DO - 10.1159/000514381
M3 - Scientific review articles
C2 - 33592618
AN - SCOPUS:85100891777
SN - 2296-5270
VL - 44
SP - 184
EP - 189
JO - Oncology Research and Treatment
JF - Oncology Research and Treatment
IS - 4
ER -